DEF 14A DEFINITIVE PROXY STATEMENT

Company

TG THERAPEUTICS, INC.

Filed

January 29, 2003

Period of Report

February 21, 2003

Accession Number

0000922423-03-000068

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →